A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Etretinate
Norgestrel
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Norgestrel.
Etretinate
Norethynodrel
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Norethynodrel.
Etretinate
Dienogest
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Dienogest.
Etretinate
Gestodene
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gestodene.
Etretinate
Cyproterone acetate
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Cyproterone acetate.
Etretinate
Drospirenone
The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Drospirenone.
Etretinate
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etretinate
Colesevelam
Colesevelam can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etretinate
Aluminum chloride
Aluminum chloride can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Etretinate
Belantamab mafodotin
Ursodeoxycholic acid may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Etretinate
Pralsetinib
Pralsetinib may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.
Etretinate
Glycyrrhizic acid
Ursodeoxycholic acid may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.
Etretinate
Dihydroergocristine
Ursodeoxycholic acid may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.
Etretinate
Pilsicainide
Ursodeoxycholic acid may decrease the excretion rate of Pilsicainide which could result in a higher serum level.
Etretinate
Benzbromarone
Ursodeoxycholic acid may decrease the excretion rate of Benzbromarone which could result in a higher serum level.
Etretinate
Indocyanine green acid form
Ursodeoxycholic acid may decrease the excretion rate of Indocyanine green acid form which could result in a higher serum level.
Etretinate
Pitavastatin
Ursodeoxycholic acid may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Etretinate
Prasterone sulfate
Ursodeoxycholic acid may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.
Etretinate
Taurocholic acid
Ursodeoxycholic acid may decrease the excretion rate of Taurocholic acid which could result in a higher serum level.
Etretinate
Glycochenodeoxycholic Acid
Ursodeoxycholic acid may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3